UPDATE: Cantor Fitzgerald Starts Seelos Therapeutics (SEEL) at Overweight
Tweet Send to a Friend
(Updated - June 1, 2021 7:00 AM EDT)
Cantor Fitzgerald analyst Charles C. Duncan initiates coverage on Seelos Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cantor Fitzgerald analyst Charles C. Duncan initiates coverage on Seelos Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
